Public Interest Group on Cancer Research: a successful patient-researcher partnership in Newfoundland and Labrador.
Cancer
Caregivers
Diversity
EDI
Family members
Newfoundland and Labrador
Patient partners
Patient partnership
Patient-oriented research
Public engagement
Journal
Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164
Informations de publication
Date de publication:
03 Sep 2022
03 Sep 2022
Historique:
received:
09
07
2022
accepted:
09
08
2022
entrez:
3
9
2022
pubmed:
4
9
2022
medline:
4
9
2022
Statut:
epublish
Résumé
Partnering with patients and family members affected by cancer is essential for meaningful research, public engagement and outreach, and advocacy activities. Our objective was to create a public interest group through an academic-community partnership focused on cancer research and public engagement. A purposeful recruitment process was implemented to ensure a diverse and inclusive group. The group meets virtually and communicates by email. The group's activities focus on identifying the needs, priorities, and interests of cancer-affected individuals in the province; consultations; and designing research projects and public outreach activities together. Comprehensive meeting minutes are kept and used to distill discussion points. The work of the group is disseminated through a variety of channels. The public interest group includes 12 cancer patient and family member representatives, in addition to researchers. Discussions by the interest group identified key themes related to: (1) equity issues and regional disparity in provincial oncocare; (2) information needs; (3) need for patient empowerment and public understanding; and (4) family member and partner needs and experiences. To date, the group has co-designed a cancer research proposal and a public engagement/outreach activity. The group also provides consultations on cancer-related projects/public engagement activities and members act as patient partners in specific research and public engagement proposals. The group evolves over time, and increasingly advocates on behalf of cancer patients and families. Retention and satisfaction of the public partners with group activities have been high. The group's work and findings are disseminated to the Provincial Cancer Care Program, as well as to public and scientific stakeholders through local media, academic conferences and presentations, and a dedicated website. Public Interest Group on Cancer Research represents a highly successful patient-researcher partnership in oncology. It designs meaningful and patient-oriented studies and outreach activities in cancer. It also elevates and widely supports cancer patient and family voice. Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.
Sections du résumé
BACKGROUND
BACKGROUND
Partnering with patients and family members affected by cancer is essential for meaningful research, public engagement and outreach, and advocacy activities.
OBJECTIVE
OBJECTIVE
Our objective was to create a public interest group through an academic-community partnership focused on cancer research and public engagement.
METHODS
METHODS
A purposeful recruitment process was implemented to ensure a diverse and inclusive group. The group meets virtually and communicates by email. The group's activities focus on identifying the needs, priorities, and interests of cancer-affected individuals in the province; consultations; and designing research projects and public outreach activities together. Comprehensive meeting minutes are kept and used to distill discussion points. The work of the group is disseminated through a variety of channels.
RESULTS
RESULTS
The public interest group includes 12 cancer patient and family member representatives, in addition to researchers. Discussions by the interest group identified key themes related to: (1) equity issues and regional disparity in provincial oncocare; (2) information needs; (3) need for patient empowerment and public understanding; and (4) family member and partner needs and experiences. To date, the group has co-designed a cancer research proposal and a public engagement/outreach activity. The group also provides consultations on cancer-related projects/public engagement activities and members act as patient partners in specific research and public engagement proposals. The group evolves over time, and increasingly advocates on behalf of cancer patients and families. Retention and satisfaction of the public partners with group activities have been high. The group's work and findings are disseminated to the Provincial Cancer Care Program, as well as to public and scientific stakeholders through local media, academic conferences and presentations, and a dedicated website.
CONCLUSION
CONCLUSIONS
Public Interest Group on Cancer Research represents a highly successful patient-researcher partnership in oncology. It designs meaningful and patient-oriented studies and outreach activities in cancer. It also elevates and widely supports cancer patient and family voice.
Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.
Autres résumés
Type: plain-language-summary
(eng)
Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.
Identifiants
pubmed: 36057599
doi: 10.1186/s40900-022-00380-8
pii: 10.1186/s40900-022-00380-8
pmc: PMC9440646
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46Subventions
Organisme : Office of Public Engagement, Memorial University
ID : Quick Start Fund
Informations de copyright
© 2022. The Author(s).
Références
Am J Bioeth. 2021 Oct;21(10):44-45
pubmed: 34554061
Eur J Hum Genet. 2020 Jul;28(7):925-937
pubmed: 32467599
Mol Genet Genomic Med. 2018 Nov;6(6):1021-1030
pubmed: 30300963
Can Fam Physician. 2015 Apr;61(4):384, 383
pubmed: 25873711
J Patient Exp. 2020 Dec;7(6):898-905
pubmed: 33457517
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):
pubmed: 26966288
Milbank Q. 2016 Mar;94(1):163-214
pubmed: 26994713
J Gen Intern Med. 2016 Jan;31(1):13-21
pubmed: 26160480
Can Fam Physician. 2017 Feb;63(2):e102-e106
pubmed: 28209701